RetinalGenix Technologies (RTGN) Total Non-Current Liabilities (2022 - 2026)
RetinalGenix Technologies' (RTGN) quarterly Total Non-Current Liabilities came in at $1.7 million in Q1 2026, up 47.7% year-on-year from $1.2 million in Q1 2025, and down 5.54% quarter-over-quarter from $1.8 million in Q4 2025.
RetinalGenix Technologies (RTGN) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
RetinalGenix Technologies has disclosed Total Non-Current Liabilities across 5 years of filings, most recently posting $1.7 million for Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $1.7 million, up 47.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (up 47.7% YoY), and the FY2025 annual result was $1.8 million, up 81.67% from the prior year.
- Total Non-Current Liabilities came in at $1.7 million for Q1 2026 at RetinalGenix Technologies, down from $1.8 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $1.8 million in Q4 2025 to a low of $459804.0 in Q2 2022.
- The 5-year median for Total Non-Current Liabilities is $1.4 million (2024), against an average of $1.3 million.
- Across the five-year window, Total Non-Current Liabilities surged 240.79% in 2023 and decreased 14.73% in 2025, its largest moves.
- RetinalGenix Technologies' Total Non-Current Liabilities stood at $959815.0 in 2022, then dropped by 1.2% to $948279.0 in 2023, then grew by 6.48% to $1.0 million in 2024, then surged by 81.67% to $1.8 million in 2025, then retreated by 5.54% to $1.7 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $1.7 million (Q1 2026), $1.8 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 2.44 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 24.21 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 3.53 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 3.47 Bn |
| 10 | RetinalGenix Technologies | - | - | - | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 948,279.00 |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 1.57 Mn |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 959,815.00 |
| Jun 30, 2022 | 459,804.00 |